ArticleKorean journal of radiology2021

Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy.

Bingjie Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.